Aurélie Verney

713 total citations
16 papers, 334 citations indexed

About

Aurélie Verney is a scholar working on Pathology and Forensic Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Aurélie Verney has authored 16 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Aurélie Verney's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (2 papers). Aurélie Verney is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (2 papers). Aurélie Verney collaborates with scholars based in France, United States and Switzerland. Aurélie Verney's co-authors include Gilles Salles, Alexandra Traverse‐Glehen, Pascale Felman, Lucile Baseggio, Françoise Berger, Sophie Gazzo, Jean‐Pierre Magaud, Martine Ffrench, Bertrand Coiffier and Dominique Morel and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Aurélie Verney

16 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aurélie Verney France	11	226	224	85	77	71	16	334
Jennifer L. Cultrera United States	8	80 0.4×	182 0.8×	202 2.4×	42 0.5×	54 0.8×	23	326
Blanche H. Mavromatis United States	8	95 0.4×	92 0.4×	69 0.8×	63 0.8×	94 1.3×	19	289
Claudia Mannu Italy	9	68 0.3×	154 0.7×	115 1.4×	54 0.7×	30 0.4×	20	214
Ronald Boonstra Netherlands	8	137 0.6×	218 1.0×	189 2.2×	27 0.4×	49 0.7×	10	301
H. Yesid Estupiñán Colombia	8	206 0.9×	138 0.6×	58 0.7×	90 1.2×	72 1.0×	18	314
Maria Luigia Vigliotti Italy	10	130 0.6×	89 0.4×	47 0.6×	68 0.9×	49 0.7×	17	309
M. Lenoci Italy	7	212 0.9×	190 0.8×	76 0.9×	131 1.7×	70 1.0×	10	362
Marieth Plummer United Kingdom	4	356 1.6×	273 1.2×	58 0.7×	199 2.6×	82 1.2×	8	465
Massimo Pini Italy	10	119 0.5×	128 0.6×	136 1.6×	115 1.5×	80 1.1×	26	382
Ewa Paszkiewicz‐Kozik Poland	10	43 0.2×	148 0.7×	164 1.9×	97 1.3×	93 1.3×	57	316

Countries citing papers authored by Aurélie Verney

Since Specialization

Citations

This map shows the geographic impact of Aurélie Verney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélie Verney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélie Verney more than expected).

Fields of papers citing papers by Aurélie Verney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélie Verney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélie Verney. The network helps show where Aurélie Verney may publish in the future.

Co-authorship network of co-authors of Aurélie Verney

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélie Verney. A scholar is included among the top collaborators of Aurélie Verney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélie Verney. Aurélie Verney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lamarche, Frédéric, Jérôme Guitton, Cécile Cottet‐Rousselle, et al.. (2024). A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity. Cell Death and Disease. 15(5). 311–311. 10 indexed citations

Veyrat‐Masson, Richard, et al.. (2024). Diagnosis of chronic B‐cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data. Hematological Oncology. 42(1). e3245–e3245. 1 indexed citations

Verney, Aurélie, Jérôme Guitton, Alexandra Traverse‐Glehen, et al.. (2024). Functional precision oncology for follicular lymphoma with patient-derived xenograft in avian embryos. Leukemia. 38(2). 430–434. 2 indexed citations

Baseggio, Lucile, Juliette Fontaine, Hervé Ghesquières, et al.. (2021). New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas. Current Oncology. 28(5). 3430–3447. 10 indexed citations

Verney, Aurélie, Alexandra Traverse‐Glehen, Evelyne Callet‐Bauchu, et al.. (2018). Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma. Oncotarget. 9(34). 23589–23598. 3 indexed citations

Jallades, Laurent, Lucile Baseggio, Pierre Sujobert, et al.. (2017). Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2 , TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica. 102(10). 1758–1766. 53 indexed citations

Medves, Sandrine, Sophie Gazzo, Delphine Poncet, et al.. (2016). A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B‐cells. British Journal of Haematology. 174(1). 57–70. 15 indexed citations

Verney, Aurélie, Sophie Gazzo, Laurent Jallades, et al.. (2016). Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies. Leukemia & lymphoma. 58(3). 666–675. 22 indexed citations

Ghesquières, Hervé, Beth R. Larrabee, Corinne Haïoun, et al.. (2016). FCGR3A/2A polymorphisms and diffuse large B‐cell lymphoma outcome treated with immunochemotherapy: a meta‐analysis on 1134 patients from two prospective cohorts. Hematological Oncology. 35(4). 447–455. 11 indexed citations

10.

Brisou, Gabriel, Kheïra Beldjord, Nicolas Mounier, et al.. (2013). Prognostic Impact Of Somatic NOTCH2 Mutation In Splenic Marginal Zone Lymphoma. Blood. 122(21). 4247–4247. 3 indexed citations

11.

Traverse‐Glehen, Alexandra, Emmanuel Bachy, Lucile Baseggio, et al.. (2013). Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases. Histopathology. 62(6). 876–893. 11 indexed citations

12.

Ghesquières, Hervé, Guillaume Cartron, John F. Seymour, et al.. (2012). Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. Blood. 120(13). 2650–2657. 46 indexed citations

13.

Baseggio, Lucile, Sophie Gazzo, Françoise Berger, et al.. (2012). In non‐follicular lymphoproliferative disorders, IGH/BCL2‐fusion is not restricted to chronic lymphocytic leukaemia. British Journal of Haematology. 158(4). 489–498. 20 indexed citations

14.

Traverse‐Glehen, Alexandra, Lucile Baseggio, Dominique Morel, et al.. (2007). Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?. Blood. 111(4). 2253–2260. 99 indexed citations

15.

Traverse‐Glehen, Alexandra, Aurélie Verney, Lucille Baseggio, et al.. (2005). Analysis of IgVH, BCL-6, PIM, RHO/TTF and PAX5 Mutational Status in Splenic and Nodal Marginal Zone B Cell Lymphoma Suggests a Particular B Cell Origin.. Blood. 106(11). 162–162. 3 indexed citations

16.

Rosalki, S B, T. G. Jones, & Aurélie Verney. (1960). Transaminase and Liver-function Studies in Infectious Mononucleosis. BMJ. 1(5177). 929–932. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact